Corcept Therapeutics
CORT
#2263
Rank
$8.55 B
Marketcap
$79.71
Share price
-0.25%
Change (1 day)
7.31%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of March 2026 : $0.63 Billion USD

According to Corcept Therapeutics 's latest financial reports the company has $0.63 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.64 B-4.68%
2024-12-31$$0.67 B34.12%
2023-12-31$$0.50 B0.97%
2022-12-31$$0.50 B33.54%
2021-12-31$$0.37 B-28.19%
2020-12-31$$0.52 B40.99%
2019-12-31$$0.37 B34.54%
2018-12-31$$0.27 B44.47%
2017-12-31$$0.19 B361.51%
2016-12-31$$41.37 M123.69%
2015-12-31$$18.49 M-645.99%
2014-12-31$-$3.39 Million-116.12%
2013-12-31$$21.01 M-65.98%
2012-12-31$$61.77 M77.48%
2011-12-31$$34.8 M63.84%
2010-12-31$$21.24 M-3.84%
2009-12-31$$22.09 M30.67%
2008-12-31$$16.9 M14.75%
2007-12-31$$14.73 M131.67%
2006-12-31$$6.36 M-76.08%
2005-12-31$$26.59 M-42.12%
2004-12-31$$45.94 M-245.99%
2003-12-31$-$31.48 Million43.45%
2002-12-31$-$21.94 Million-198.06%
2001-12-31$$22.37 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.18 B 12,625.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$38.92 B 6,001.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$90.40 B 14,070.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$31.19 B 4,790.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$45.93 B 7,099.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$20.10 B 3,050.85%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-$59.2 Million-109.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.46 Billion-170.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.21 B 873.70%๐Ÿ‡บ๐Ÿ‡ธ USA